Apple is making another attempt to appeal the trade ban that forced it to remove the blood oxygen sensor from its smartwatches, Reuters reports. The company was forced to remove the feature in 2024, following a decision from the International Trade Commission (ITC) in 2023 that banned sales of the Apple Watch for violating health tech startup Masimo's patents.<br /> The US Court of Appeals for the Federal Circuit heard new arguments from Apple and Masimo's lawyers on Monday over the legality of the original ITC ban. Apple's argument is that the fact Masimo was developing its own smartwatch when Apple released the Apple Watch Series 6 in 2020 — the first of the company's wearables with a blood oxygen sensor — shouldn't be enough to justify the ban. Masimo [...]
Masimo, the medical technology company whose lawsuit led to the temporary sales pause of the Apple Watch Series 9 and Ultra 2, has sued the US Customs and Border Protection days after Apple released i [...]
We called 2023’s Galaxy Watch 6 a “modest upgrade” from the Galaxy Watch 5, which itself also got described as “very similar” to its predecessor, the Watch 4. So it’s perhaps not surprisin [...]
More than a year after an import ban forced the company to remove blood oxygen monitoring from some US Apple Watch models, Apple says it will introduce a redesigned version of the feature later today. [...]
Dear Apple,<br /> As you know, your Apple Watch SE is not new. The second generation came out in September 2022 alongside the Series 8 and the first iteration of the Ultra. You’ve given the iP [...]